Shanghai HeartCare Medical Technology Corporation Limited (06609) disclosed an update to its share structure on 23 January 2026. The company repurchased 40,000 H shares and increased its treasury shares from 932,400 to 972,400. Following the transaction, the number of issued H shares (excluding treasury shares) decreased from 30,633,404 to 30,593,404, while the total issued shares (including unlisted shares) remained at 31,565,804.

According to the disclosure, the buyback occurred on 23 January 2026, with the repurchase price ranging from HKD 54.50 to HKD 57.45 per share and an aggregate purchase amount of HKD 2,258,165. The unlisted portion, consisting of 7,268,604 shares, remains unchanged. The company also confirmed that the share repurchase complied with all relevant regulations and received board authorization.